Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Levitzki

Showing results (21-30 of 244) with videos related to

Pageof 25
Sort By:
Biochemical Pharmacology|September 1, 1990
Tyrphostins--potential antiproliferative agents and novel molecular toolsA Levitzki
Pharmacology & Therapeutics|August 24, 1999
Protein tyrosine kinase inhibitors as novel therapeutic agentsA Levitzki
Annals of the New York Academy of Sciences|September 7, 1995
Signal transduction interception as a novel approach to disease managementA Levitzki
Analytical Biochemistry|February 1, 1970
Determination of submicro quantities of ammoniaA Levitzki
Science (New York, N.Y.)|August 12, 1988
From epinephrine to cyclic AMPA Levitzki
Cell Biophysics|January 1, 1988
Signal transduction in hormone-dependent adenylate cyclaseA Levitzki
Ernst Schering Research Foundation Workshop|June 8, 2001
The selectivity of small molecules towards protein tyrosine kinasesA Levitzki
CRC Critical Reviews in Biochemistry|January 1, 1981
The beta-adrenergic receptor and its mode of coupling to adenylate cyclaseA Levitzki
European Journal of Biochemistry|November 15, 1994
Signal-transduction therapy. A novel approach to disease managementA Levitzki
Biochimica Et Biophysica Acta|June 12, 1985
Reconstitution of membrane receptor systemsA Levitzki
Pageof 25

Showing results (21-30 of 244) with videos related to

Sort By:
Pageof 25
Biochemical Pharmacology|September 1, 1990
Tyrphostins--potential antiproliferative agents and novel molecular toolsA Levitzki
Pharmacology & Therapeutics|August 24, 1999
Protein tyrosine kinase inhibitors as novel therapeutic agentsA Levitzki
Annals of the New York Academy of Sciences|September 7, 1995
Signal transduction interception as a novel approach to disease managementA Levitzki
Analytical Biochemistry|February 1, 1970
Determination of submicro quantities of ammoniaA Levitzki
Science (New York, N.Y.)|August 12, 1988
From epinephrine to cyclic AMPA Levitzki
Cell Biophysics|January 1, 1988
Signal transduction in hormone-dependent adenylate cyclaseA Levitzki
Ernst Schering Research Foundation Workshop|June 8, 2001
The selectivity of small molecules towards protein tyrosine kinasesA Levitzki
CRC Critical Reviews in Biochemistry|January 1, 1981
The beta-adrenergic receptor and its mode of coupling to adenylate cyclaseA Levitzki
European Journal of Biochemistry|November 15, 1994
Signal-transduction therapy. A novel approach to disease managementA Levitzki
Biochimica Et Biophysica Acta|June 12, 1985
Reconstitution of membrane receptor systemsA Levitzki
Pageof 25